[Pharmacological study of phenylbutazone trimethylgallic ester (LH-150): blood levels and anti-inflammatory activity].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002351:Carrageenan; D004487:Edema / Q000188:drug therapy*; D005549:Foreign-Body Reaction / Q000188:drug therapy; D005707:Gallic Acid / Q000097:blood / Q000627:therapeutic use; D003368:Gossypium; D006099:Granuloma / Q000188:drug therapy*; D008738:Methyl Ethers / Q000097:blood / Q000627:therapeutic use; D010653:Phenylbutazone / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use* / Q000031:analogs & derivatives; D051381:Rats
D000893:Anti-Inflammatory Agents; D008738:Methyl Ethers; C002131:phenylbutazone trimethylgallate; D005707:Gallic Acid; D002351:Carrageenan; D010653:Phenylbutazone
Etude pharmacologique de l'ester triméthylgallique de phénylbutazon (LH-150): taux sanguins et activité anti-inflammatoire.